Phenotypic and Genotypic Variations of Enterococcus Spp
NCT05751317 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2023-04-19
Summary
Enterococci are Gram-positive facultative anaerobic cocci arranged in short and medium chains. Enterococci reside in the gastrointestinal tract and usually function commensally with humans. They can, however, cause several infections, such as urinary tract infections (UTIs), intra-abdominal infection, bacteremia, or endocarditis.
Among many species identified, E. faecalis and E. faecium are the most common species capable of causing infection and posing a threat of antimicrobial resistance, with E. faecalis accounting for the majority of infections.
Conditions
- Isolation of Enterococci From Samples
- Demonstration of Enterococci Antibiotic Susceptibility
- Detection of Strains Enterococci Produce Biofilm
- Studying Effect of Nanoparticles on Enterococci Antimicrobial Resistance
- Studying Effect of Nanoparticles on Enterococci Biofilm
- Genotyping of Enterococci
Interventions
- DIAGNOSTIC_TEST
-
Culture
* Samples will be transported to Medical Microbiology and Immunology Laboratory and will be inoculated on MacConkey medium. * Pink colonies will be inoculated on bile esculin agar medium. * Enterococci produce blackening of the agar
- DIAGNOSTIC_TEST
-
Staining:
The growing colonies on bile esculin agar medium will be examined microscopically after staining by Gram stain.
- DIAGNOSTIC_TEST
-
Biochemical reactions:
* Catalase test. * Salt tolerance test
- DIAGNOSTIC_TEST
-
VITEK
Automated identification of Enterococci will be done with VITEK2 system.
- DIAGNOSTIC_TEST
-
Antibiotic sensitivity test
Strains confirmed as Enterococci will be examined for their antibiotic susceptibility by modified Kirby Bauer's disc diffusion method on Mueller-Hinton Agar.
- DIAGNOSTIC_TEST
-
nanoparticles effect
The effect of nanoparticles on Enterococci antimicrobial resistance pattern
- DIAGNOSTIC_TEST
-
The biofilm formation activity
The biofilm formation activity of Enterococci isolates will be tested using the microtiter plate technique
- DIAGNOSTIC_TEST
-
molecular diagnosis
Molecular identification of some virulence factors genes and antibiotic resistance genes of Enterococci using PCR
Sponsors & Collaborators
-
Sohag University
lead OTHER
Principal Investigators
-
Mona F Mohamed, professor · Sohag University
-
Wesam A Abu El wafa · Sohag University
Eligibility
- Min Age
- 1 Month
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-04-01
- Primary Completion
- 2023-12-31
- Completion
- 2024-03-30
Countries
- Egypt
Study Locations
More Related Trials
-
Can the Relative Fecal Abundance of BLSE and the Digestive Microbiota be Predictive of the Risk of Infection in a Carrier Patient?
NCT04699981 ·Status: UNKNOWN ·Phase: NA
-
Existence in the Human Digestive Flora of Phages Able to Prevent the Acquisition of Multiresistant Enterobacteria
NCT03231267 ·Status: UNKNOWN
-
Detection of Biofilm Among Uropathogenic Escherichia Coli Clinical Isolates in Suez Canal University Hospitals
NCT06252428 ·Status: COMPLETED
-
Antimicrobial Resistance Rate In Escherichia Coli And Klebsiella Pneumonia : A Retrospective Study
NCT04196387 ·Status: COMPLETED
-
Impact of Beta-lactams on the Microbiota and Relative Fecal Abundance of Mulltidrug Resistant Bacteria
NCT03338738 ·Status: COMPLETED ·Phase: NA
-
Gut Microbiota Association With ESBL-E Colonisation and Subsequent ESBL-E Infection
NCT04131569 ·Status: UNKNOWN
-
Transmission of ESBL-producing Enterobacteriaceae
NCT03465683 ·Status: RECRUITING
-
Identification of Gut Microbiome Biomarkers Associated to Acquisition of Enterobacteriae Highly Resistant to Third Generation Cephalosporines Following Ceftriaxone Treatment.
NCT03569917 ·Status: TERMINATED ·Phase: NA
-
Characterization of Enterococcus Faecalis Endocarditis and Impact of Amoxicillin MIC Elevation on Patient Outcome
NCT05530837 ·Status: COMPLETED
-
Ampicillin-sulbactam Resistant E.Coli at UPMC
NCT00619580 ·Status: WITHDRAWN
-
Study Evaluating the Etiology of Intra-Abdominal Infections
NCT00244088 ·Status: COMPLETED
-
Microbial Epidemiology and Chlorhexidine Suscebtibily of Oropharyngeal and Intestinal Colonization
NCT02840656 ·Status: COMPLETED
-
Selective Reporting for Antibiotic Susceptibility Testing and GPs' Prescribing of Broad-spectrum Antibiotics in Women With E. Coli UTIs
NCT06067386 ·Status: UNKNOWN ·Phase: NA
-
Concomitant Infection of Intestinal Parasites and Helicobacter Pylori
NCT05360940 ·Status: UNKNOWN
-
Impact of Ceftriaxone and/or Fluoroquinolone (FQ) Treatment on the Gut Microbiota of Hospitalized Patients.
NCT02031588 ·Status: TERMINATED
-
Detection of Anaerobes in Different Clinicalsamples
NCT03266341 ·Status: UNKNOWN
-
Short vs Long of Usual Treatment for Non Complicated Enterococcal Bacteremia
NCT05394298 ·Status: UNKNOWN ·Phase: PHASE4
-
Multi-resistant Enterobacteriaceae Colonisation in Less Than 32 Weeks Pregnant Women Admitted to the Hospital.
NCT02631226 ·Status: UNKNOWN
-
Intensive Care Unit Acquired Infections in Patients Colonized With Extended Spectrum Enterobacteriaceae
NCT04903886 ·Status: UNKNOWN
-
Community - Associated Extended-spectrum Beta-lactamases (ESBL)
NCT00363220 ·Status: COMPLETED
-
Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms
NCT01324726 ·Status: COMPLETED
-
Role of N-Acetylcysteine in Treatment of Bacterial Vaginosis
NCT01841411 ·Status: UNKNOWN ·Phase: PHASE4
-
Antibiotic Resistant Community-Acquired E. Coli
NCT00298103 ·Status: COMPLETED
-
Dynamics of the Urinary Bacterial Microbiota
NCT07020676 ·Status: COMPLETED
-
Evaluation of Heterologous Fecal microbiotA Transfer in ICU Patients: a FeasibilitY and SafetY StudY
NCT03350178 ·Status: TERMINATED ·Phase: PHASE2